Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics and safety of transdermal megestrol acetate

Trial Profile

Pharmacokinetics and safety of transdermal megestrol acetate

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2013

At a glance

  • Drugs Megestrol (Primary)
  • Indications Breast cancer; Endometrial cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 May 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top